Transcutaneous lisuride therapy of Parkinson's disease
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2017
At a glance
- Drugs Lisuride (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 04 Jun 2008 Axxonis submitted MAA to EMEA for transdermal lisuride as add-on therapy for Parkinson's Disease and Restless Legs Syndrome.
- 25 Oct 2005 New trial record.